EGFR testing by a new diagnostic method to detect point mutations, deletions and insertions associated to non small cell lung cancer: CLARTCMA EGFR.
Journal of Clinical Oncology（2015）
摘要
e19095 Background: The Epidermal Growth Factor Receptor (EGFR) mutation status is an important clinical variable for treatment indication in non-small-cell lung cancer (NSCLC). Around 30% NSCLC car...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要